Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Capital Expenditures (2016 - 2026)

Bio-Techne has reported Capital Expenditures over the past 17 years, most recently at $5.9 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 13.19% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $26.3 million, down 47.84%, while the annual FY2025 figure was $31.0 million, 50.69% down from the prior year.
  • Capital Expenditures for Q4 2025 was $5.9 million at Bio-Techne, up from $5.4 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $18.0 million in Q2 2024 and troughed at $4.9 million in Q2 2025.
  • A 5-year average of $10.5 million and a median of $10.4 million in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: soared 143.31% in 2023 and later tumbled 72.8% in 2025.
  • Year by year, Capital Expenditures stood at $10.2 million in 2021, then plummeted by 39.92% to $6.1 million in 2022, then skyrocketed by 143.31% to $14.9 million in 2023, then crashed by 54.11% to $6.8 million in 2024, then decreased by 13.19% to $5.9 million in 2025.
  • Business Quant data shows Capital Expenditures for TECH at $5.9 million in Q4 2025, $5.4 million in Q3 2025, and $4.9 million in Q2 2025.